UNITED GUARDIAN INC (UG): Nasdaq/NYSE listing notice — United-Guardian faces Nasdaq delisting for MVLS, equity, and revenue non-compliance

UNITED GUARDIAN INC

Received Nasdaq deficiency letter on April 20, 2023; market value below $50M for 30 consecutive days.
Also failed Stockholders' Equity ($10M min) and Total Assets/Total Revenue ($50M min) requirements.
Has until Oct 17, 2023 to regain MVLS compliance; must submit compliance plan by June 5, 2023 for other items.
Plans to submit compliance plan; no assurance of regaining compliance; delisting and appeal process possible.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

UNITED GUARDIAN INC received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A), 5810(c)(3)(C)

Exact text from the filing

April 20, 2023, United-Guardian, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) (the “Minimum MVLS Requirement”) for continued listing on the Nasdaq Global Select Market, as the market value of the Company’s listed securities was less than $50,000,000 for the previous thirty (30) consecutive business days. In accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the “Compliance Period Rule”), the Company ha

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

UNITED GUARDIAN INC filing history →

Source: SEC EDGAR

accession 0001171843-23-002573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.